buy medicine online indiamedicine online

    Glimepiride + Metformin + Voglibose

    Information about Glimepiride + Metformin + Voglibose

    Glimepiride + metformin + voglibose uses

    Glimepiride+Metformin+Voglibose is used in the treatment of type 2 diabetes.

    How glimepiride + metformin + voglibose works

    This is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.

    Common side effects of glimepiride + metformin + voglibose

    Hypoglycemia (low blood sugar level), Nausea, Diarrhoea, Altered taste, Flatulence, Stomach pain, Headache, Skin rash, Respiratory tract infection

    Available Medicine for Glimepiride + Metformin + Voglibose

    • ₹117 to ₹160
      USV Ltd
      6 variant(s)
    • ₹122 to ₹162
      Sun Pharmaceutical Industries Ltd
      2 variant(s)
    • ₹45 to ₹233
      Eris Life Sciences Pvt Ltd
      7 variant(s)
    • ₹107 to ₹279
      Alkem Laboratories Ltd
      5 variant(s)
    • ₹100 to ₹127
      Mankind Pharma Ltd
      2 variant(s)
    • ₹120 to ₹162
      Sun Pharmaceutical Industries Ltd
      4 variant(s)
    • ₹126 to ₹166
      Intas Pharmaceuticals Ltd
      2 variant(s)
    • ₹114 to ₹146
      Macleods Pharmaceuticals Pvt Ltd
      4 variant(s)
    • ₹94 to ₹116
      Sun Pharmaceutical Industries Ltd
      2 variant(s)
    • ₹104 to ₹133
      Alembic Pharmaceuticals Ltd
      2 variant(s)

    Content on this page was last updated on 13 April, 2018, by Dr. Varun Gupta (MD Pharmacology)